These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2910452

  • 21. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek I, Sliwinski T, Poplawski T, Pytel D, Kowalski M, Slupianek A, Skorski T, Blasiak J.
    Mutat Res; 2006 Jan 31; 603(1):74-82. PubMed ID: 16388976
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
    Ogawa K, Tashima M, Toi T, Sawai H, Sawada H, Fujita J, Maruyama Y, Okuma M.
    Exp Hematol; 1994 Jan 31; 22(1):45-51. PubMed ID: 7506674
    [Abstract] [Full Text] [Related]

  • 23. Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.
    Shiotsu Y, Neckers LM, Wortman I, An WG, Schulte TW, Soga S, Murakata C, Tamaoki T, Akinaga S.
    Blood; 2000 Sep 15; 96(6):2284-91. PubMed ID: 10979978
    [Abstract] [Full Text] [Related]

  • 24. [Effect of combination of herbimycin A, an inhibitor of tyrosine kinase, and chemotherapeutic agents on apoptosis of K562 cells].
    Ren H, Chen S, Lu D.
    Zhonghua Xue Ye Xue Za Zhi; 1997 May 15; 18(5):227-30. PubMed ID: 15622750
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei S, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R.
    Oncogene; 2002 Dec 12; 21(57):8804-16. PubMed ID: 12483533
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 31. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
    Niitsu N, Yamamoto-Yamaguchi Y, Miyoshi H, Shimizu K, Ohki M, Umeda M, Honma Y.
    Cell Growth Differ; 1997 Mar 15; 8(3):319-26. PubMed ID: 9056674
    [Abstract] [Full Text] [Related]

  • 32. Human IL-3 receptor signaling: rapid induction of phosphatidylcholine hydrolysis is independent of protein kinase C but dependent on tyrosine phosphorylation in transfected NIH 3T3 cells.
    Rao P, Kitamura T, Miyajima A, Mufson RA.
    J Immunol; 1995 Feb 15; 154(4):1664-74. PubMed ID: 7836750
    [Abstract] [Full Text] [Related]

  • 33. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
    Leduc I, Haddad P, Giasson E, Meloche S.
    Mol Pharmacol; 1995 Oct 15; 48(4):582-92. PubMed ID: 7476882
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T.
    Oncogene; 2008 Aug 07; 27(34):4678-89. PubMed ID: 18427551
    [Abstract] [Full Text] [Related]

  • 35. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W, Mivechi NF.
    Exp Cell Res; 2001 Apr 01; 264(2):193-200. PubMed ID: 11262176
    [Abstract] [Full Text] [Related]

  • 36. Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity.
    Bueno-da-Silva AE, Brumatti G, Russo FO, Green DR, Amarante-Mendes GP.
    Cell Death Differ; 2003 May 01; 10(5):592-8. PubMed ID: 12728257
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cells.
    Okabe M, Kawamura K, Miyagishima T, Itaya T, Goodwyn D, Shoji M, Vogler WR, Sakurada K, Uehara M, Miyazaki T.
    Leuk Res; 1994 Mar 01; 18(3):213-20. PubMed ID: 7511193
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.